Cargando…

Clinical Considerations for a Family with Dilated Cardiomyopathy, Sudden Cardiac Death, and a Novel TTN Frameshift Mutation

Dilated cardiomyopathy (DCM) is the leading indication for heart transplantation. TTN gene truncating mutations account for about 25% of familial DCM cases and for 18% of sporadic DCM cases. The clinical relevance of specific variants in TTN has been difficult to determine because of the sheer size...

Descripción completa

Detalles Bibliográficos
Autores principales:	Micaglio, Emanuele, Monasky, Michelle M., Bernardini, Andrea, Mecarocci, Valerio, Borrelli, Valeria, Ciconte, Giuseppe, Locati, Emanuela T., Piccoli, Marco, Ghiroldi, Andrea, Anastasia, Luigi, Pappone, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826882/ https://www.ncbi.nlm.nih.gov/pubmed/33445410 http://dx.doi.org/10.3390/ijms22020670

Ejemplares similares

Novel SCN5A p.Val1667Asp Missense Variant Segregation and Characterization in a Family with Severe Brugada Syndrome and Multiple Sudden Deaths
por: Monasky, Michelle M., et al.
Publicado: (2021)

SCN5A Nonsense Mutation and NF1 Frameshift Mutation in a Family With Brugada Syndrome and Neurofibromatosis
por: Micaglio, Emanuele, et al.
Publicado: (2019)

The omics of channelopathies and cardiomyopathies: what we know and how they are useful
por: Pappone, Carlo, et al.
Publicado: (2020)

Genotype–Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene
por: Monasky, Michelle M., et al.
Publicado: (2019)

Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy?
por: Pappone, Carlo, et al.
Publicado: (2020)

Novel SCN5A p.V1429M Variant Segregation in a Family with Brugada Syndrome
por: Monasky, Michelle M., et al.
Publicado: (2020)

Calcium in Brugada Syndrome: Questions for Future Research
por: Monasky, Michelle M., et al.
Publicado: (2018)

Further Considerations in Childhood-Onset Hypertrophic Cardiomyopathy Genetic Testing
por: Monasky, Michelle M., et al.
Publicado: (2021)

Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome
por: Micaglio, Emanuele, et al.
Publicado: (2019)

Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype
por: Micaglio, Emanuele, et al.
Publicado: (2019)

Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies
por: Ghiroldi, Andrea, et al.
Publicado: (2018)

Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene
por: Monasky, Michelle M., et al.
Publicado: (2019)

Alterations of the Sialylation Machinery in Brugada Syndrome
por: Ghiroldi, Andrea, et al.
Publicado: (2022)

Evaluating the Use of Genetics in Brugada Syndrome Risk Stratification
por: Monasky, Michelle M., et al.
Publicado: (2021)

Brugada syndrome genetics is associated with phenotype severity
por: Ciconte, Giuseppe, et al.
Publicado: (2020)

Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death
por: Pappone, Carlo, et al.
Publicado: (2023)

Brugada Syndrome: Oligogenic or Mendelian Disease?
por: Monasky, Michelle M., et al.
Publicado: (2020)

Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value
por: Pappone, Carlo, et al.
Publicado: (2021)

Epicardial ablation in genetic cardiomyopathies: a new frontier
por: Pappone, Carlo, et al.
Publicado: (2019)

Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in TTN
por: Rodriguez-Polo, Ignacio, et al.
Publicado: (2022)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Intraventricular Septation in the Context of Dilated Cardiomyopathy Associated With TTN Mutation
por: Khandalavala, Karl R., et al.
Publicado: (2021)

Brugada Syndrome: Warning of a Systemic Condition?
por: D'Imperio, Sara, et al.
Publicado: (2021)

Commentary: Next Generation Sequencing and Linkage Analysis for the Molecular Diagnosis of a Novel Overlapping Syndrome Characterized by Hypertrophic Cardiomyopathy and Typical Electrical Instability of Brugada Syndrome
por: Monasky, Michelle M., et al.
Publicado: (2017)

GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells
por: Bergante, Sonia, et al.
Publicado: (2018)

HIF-1α Directly Controls WNT7A Expression During Myogenesis
por: Cirillo, Federica, et al.
Publicado: (2020)

Upregulation of Yy1 Suppresses Dilated Cardiomyopathy caused by Ttn insufficiency
por: Liao, Dan, et al.
Publicado: (2019)

Sudden death of a patient with epilepsy: When Brugada syndrome mimicry can be fatal
por: Negro, Gabriele, et al.
Publicado: (2021)

Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
por: Bernardini, Andrea, et al.
Publicado: (2021)

Low mutation rate in the TTN gene in paediatric patients with dilated cardiomyopathy – a pilot study
por: Zaklyazminskaya, Elena, et al.
Publicado: (2019)

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy
por: Roggenbuck, Jennifer, et al.
Publicado: (2019)

Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy
por: Xiao, Lei, et al.
Publicado: (2021)

A Novel Nonsense Pathogenic TTN Variant Identified in a Patient with Severe Dilated Cardiomyopathy
por: Micolonghi, Caterina, et al.
Publicado: (2023)

A hypertrophic and dilated cardiomyopathic sudden cardiac death case; de novo mutations in TTN and SGCD genes
por: Baydar, Çetin Lütfi, et al.
Publicado: (2016)

Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability
por: La Rocca, Paolo, et al.
Publicado: (2023)

Commentary: Peptide-Based Targeting of the L-Type Calcium Channel Corrects the Loss-of-Function Phenotype of Two Novel Mutations of the CACNA1 Gene Associated With Brugada Syndrome
por: Monasky, Michelle M., et al.
Publicado: (2021)

Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm
por: Pappone, Carlo, et al.
Publicado: (2021)

Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome
por: Locati, Emanuela T, et al.
Publicado: (2023)

Novel JAG1 Deletion Variant in Patient with Atypical Alagille Syndrome
por: Micaglio, Emanuele, et al.
Publicado: (2019)

The Mechanism of Ajmaline and Thus Brugada Syndrome: Not Only the Sodium Channel!
por: Monasky, Michelle M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8a1es8tlilba4m540he3ditqj